XML 24 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2016
Cash flows from operating activities:      
Net (loss) income $ (119,351) $ 92,425 $ (82,438)
Adjustments to reconcile net (loss) income to net cash provided by operating activities:      
Depreciation, depletion and amortization 163,696 159,636 141,108
Amortization of debt discount and issuance costs 15,046 13,825 12,985
Non-cash employee stock compensation expense 8,279 9,983 10,039
Impairment of stream and royalty interests 239,364   98,588
Gain on available-for-sale securities     (2,340)
Deferred tax benefit (32,843) 1,556 (4,983)
Other (197) (4,874) (390)
Changes in assets and liabilities:      
Royalty receivables 530 (6,883) 19,508
Stream inventory (1,428) 1,606 (7,203)
Income tax receivable 22,130 (13,056) (14,637)
Prepaid expenses and other assets 2,813 (1,691) (153)
Accounts payable 5,173 (206) (849)
Income tax payable 12,601 2,475 460
Withholding taxes payable (171) 1,411 (2,486)
Uncertain tax positions 7,767 8,631 1,867
Other liabilities 5,415 2,015 235
Net cash provided by operating activities 328,824 266,853 169,311
Cash flows from investing activities:      
Acquisition of stream and royalty interests (11,812) (203,721) (1,346,109)
Repayment of Golden Star term loan 20,000    
Purchase of available-for-sale securities (17,869)    
Andacollo royalty termination     345,000
Golden Star term loan     (20,000)
Sale of available-for-sale securities     11,905
Other (909) 3,605 (309)
Net cash used in investing activities (10,590) (200,116) (1,009,513)
Cash flows from financing activities:      
Repayment of revolving credit facility (250,000) (95,000) (75,000)
Net payments from issuance of common stock (4,042) (2,426) (353)
Common stock dividends (64,118) (61,396) (58,720)
Debt issuance costs (180) (3,340) (1,111)
Borrowings from revolving credit facility   70,000 350,000
Purchase of additional royalty interest from non-controlling interest   (2,518)  
Other 3,009 (2,843) (830)
Net cash (used in) provided by financing activities (315,331) (97,523) 213,986
Net increase (decrease) in cash and equivalents 2,903 (30,786) (626,216)
Cash and equivalents at beginning of period 85,847 116,633 742,849
Cash and equivalents at end of period $ 88,750 $ 85,847 $ 116,633